Related Experiment Video
Updated: Sep 20, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Simplified regimens for treating HIV infection and AIDS
Peter J Piliero1, Joseph P Colagreco
1Division of Clinical Pharmacology, Albany Medical College, Albany, New York, USA.
Purpose:
To review the variables that greatly affect adherence to the complex treatment regimens used in HIV disease and to examine available options that could improve patient outcomes.
Data Sources:
Comprehensive review of current medical and scientific literature, drug-prescribing literature, and randomized clinical trials of drug treatments.
Conclusions:
Effective treatment of HIV infection is dependent on consistent adherence to prescribed antiretroviral medications. A large pill burden, multiple daily doses, and adverse events are some of the complexities that negatively impact patient adherence. For example, lipodystrophy and hyperlipidemia are two serious side effects associated with some agents. Once-daily antiretroviral agents offer many advantages over historical treatment options but are associated with possible drawbacks.
Implications For Practice:
Currently, four single agents are available for once-daily administration, and a few others are under investigation. In addition, combination therapy with either dual or boosted protease inhibitor regimens is becoming a popular way of overcoming the poor pharmacokinetic characteristics of individual protease inhibitors.
Related Concept Videos
Retrovirus Life Cycles
Dosage Regimens: Designs and Approaches
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Inhibitors of Virion Maturation and Assembly
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Antiviral Nucleoside Inhibitors

